首页> 美国卫生研究院文献>Heart International >The association of microalbuminuria with mortality in patients with acute myocardial infarction. A ten-year follow-up study
【2h】

The association of microalbuminuria with mortality in patients with acute myocardial infarction. A ten-year follow-up study

机译:急性心肌梗死患者微量白蛋白尿与死亡率的关系。十年随访研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Our study evaluates the long-term effect of microalbuminuria on mortality among patients with acute myocardial infarction. We followed 151 patients from 1996 to 2007 to investigate if microalbuminuria is a risk factor in coronary heart disease. All patients admitted with acute myocardial infarction in 1996 were included. At baseline, we recorded urinary albumin/creatinine concentration ratio, body mass index, blood pressure, left ventricle ejection fraction by echocardiography, smoking status, medication, diabetes, age, and gender. Deaths were traced in 2007 by means of the Danish Personal Identification Register. Microalbuminuria, defined as a urinary albumin/creatinine concentration ratio above 0.65 mg/mmoL, occurred in 50% of the patients and was associated with increased all-cause mortality. Thus, 68% of the patients with microalbuminuria versus 48% of the patients without microalbuminuria had died during the 10 years of follow-up (P=0.04). The crude hazard ratio for death associated with microalbuminuria was 1.78 (CI: 1.18–2.68) (P=0.006), whereas the gender- and age-adjusted hazard ratio was 1.71 (CI: 1.03–2.83) (P=0.04). We concluded that microalbuminuria in hospitalized patients with acute myocardial infarction is prognostic for increased long-term mortality. We recommend measurement of microalbuminuria to be included as a baseline risk factor in patients with acute myocardial infarction and in future trials in patients with coronary heart disease.
机译:我们的研究评估了微量白蛋白尿对急性心肌梗死患者死亡率的长期影响。我们从1996年至2007年追踪了151例患者,以调查微量白蛋白尿是否是冠心病的危险因素。包括所有1996年入院的急性心肌梗死患者。在基线时,我们通过超声心动图,吸烟状况,药物,糖尿病,年龄和性别记录了尿白蛋白/肌酐浓度比,体重指数,血压,左心室射血分数。 2007年,通过丹麦个人身份登记簿对死亡进行了追溯。微量白蛋白尿定义为尿白蛋白/肌酐浓度比超过0.65 mg / mmoL,发生在50%的患者中,并与全因死亡率增加相关。因此,在随访的10年中,有68%的微量白蛋白尿患者与48%的没有微量白蛋白尿的患者死亡(P = 0.04)。与微量白蛋白尿有关的死亡的总危险比为1.78(CI:1.18–2.68)(P = 0.006),而按性别和年龄调整的危险比为1.71(CI:1.03–2.83)(P = 0.04)。我们得出的结论是,住院急性心肌梗死患者的微量白蛋白尿可预示长期死亡率增加。我们建议在急性心肌梗死患者以及冠心病患者的未来试验中将微量白蛋白尿的测量作为基线危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号